次世代シーケンスのグローバル市場2023~2027:学術研究、臨床研究、製薬・バイオテクノロジー企業、その他

【英語タイトル】Global Next Generation Sequencing Market 2023-2027

Technavioが出版した調査資料(IRTNTR71618-23)・商品コード:IRTNTR71618-23
・発行会社(調査会社):Technavio
・発行日:2023年4月21日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の調査レポートによると、世界の次世代シーケンス市場規模が、予測期間中(2022-2027年)にCAGR 12.45%増加し、3,409.76百万ドルへ到達すると推測されています。本レポートでは、次世代シーケンスの世界市場を総合的に調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模・予測、過去の市場規模、ファイブフォース分析、エンドユーザー別(学術研究、臨床研究、製薬・バイオテクノロジー企業、その他)分析、種類別(消耗品、機器)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、カナダ、中国、イギリス)分析、成長要因・課題・動向、企業状況、企業分析などの内容をまとめています。並びに、市場調査の対象企業には、10X Genomics Inc.、Azenta Inc.、BGI Genomics Co. Ltd.、Bio Rad Laboratories Inc.、Eurofins Scientific SE、F. Hoffmann La Roche Ltd.、Illumina Inc.、Konica Minolta Inc.、Laboratory Corp. of America Holdings、Merck KGaA、Nabsys Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の次世代シーケンス市場規模:エンドユーザー別
- 学術研究における市場規模
- 臨床研究における市場規模
- 製薬・バイオテクノロジー企業における市場規模
- その他エンドユーザーにおける市場規模
・世界の次世代シーケンス市場規模:種類別
- 消耗品の市場規模
- 機器の市場規模
・顧客状況
・世界の次世代シーケンス市場規模:地域別
- 北米の次世代シーケンス市場規模
- ヨーロッパの次世代シーケンス市場規模
- アジアの次世代シーケンス市場規模
- その他地域の次世代シーケンス市場規模
- アメリカの次世代シーケンス市場規模
- ドイツの次世代シーケンス市場規模
- カナダの次世代シーケンス市場規模
- 中国の次世代シーケンス市場規模
- イギリスの次世代シーケンス市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの肝要な変数の分析をし、多種の情報源からのデータを調査、統合、および総括することにより、次世代シーケンス市場の明細な全容を示します。主要産業のインフルエンサーを限定することにより、市場の様々な側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な次世代シーケンス市場の成長を推測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選定手法と分析を提供します。

次世代シーケンスの世界市場 2023-2027

次世代シーケンス市場は2022年から2027年にかけて3,409.76百万米ドルの成長が予測され、予測期間中のCAGRは12.45%で加速すると予測されます。
当レポートでは、次世代シーケンス市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。NGS法の利用拡大、遺伝性疾患の早期診断に対する需要の高まり、幅広いNGS製品の入手可能性などが市場を牽引しています。

Technavio社の次世代シーケンス市場は以下のように区分されています:

・エンドユーザー別:
- 学術研究
- 臨床研究
- 製薬・バイオテクノロジー企業
- その他

・製品別:
- 消耗品
- 機器

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、NGS技術の進歩が今後数年間の次世代シーケンス市場の成長を促進する主な理由の1つであると特定しています。また、遺伝子シーケンスのコスト削減、バイオインフォマティクスやクラウドベースのソフトウェアプログラムの開発は、市場の大きな需要につながるでしょう。

次世代シーケンス市場に関するレポートは以下の分野をカバーしています:
- 次世代シーケンス市場の規模
- 次世代シーケンス市場予測
- 次世代シーケンス市場の産業分析

強固なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、10X Genomics Inc. Ltd.、Bio Rad Laboratories Inc.、Eurofins Scientific SE、F. Hoffmann La Roche Ltd.、Illumina Inc.、Konica Minolta Inc.、Laboratory Corp. of America Holdings、Merck KGaA、Nabsys Inc.、OPKO Health Inc.、Oxford Nanopore Technologies plc、Perkin Elmer Inc.、PierianDx Inc.、Psomagen Inc.、QIAGEN NV、Standard BioTools Inc.、Takara Bio Inc.、Thermo Fisher Scientific Inc.などの企業情報が含まれています。また、次世代シーケンス市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global next generation sequencing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global next generation sequencing market 2017 – 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Academic research – Market size and forecast 2022-2027
o Exhibit 34: Chart on Academic research – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Academic research – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Academic research – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Academic research – Year-over-year growth 2022-2027 (%)
o 6.4 Clinical research – Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinical research – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinical research – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinical research – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinical research – Year-over-year growth 2022-2027 (%)
o 6.5 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 42: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 6.6 Others – Market size and forecast 2022-2027
o Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by End-user
o Exhibit 50: Market opportunity by End-user ($ million)
o Exhibit 51: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 52: Chart on Product – Market share 2022-2027 (%)
o Exhibit 53: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 54: Chart on Comparison by Product
o Exhibit 55: Data Table on Comparison by Product
o 7.3 Consumables – Market size and forecast 2022-2027
o Exhibit 56: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Consumables – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
o 7.4 Equipment – Market size and forecast 2022-2027
o Exhibit 60: Chart on Equipment – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Equipment – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Equipment – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Equipment – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 64: Market opportunity by Product ($ million)
o Exhibit 65: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 103: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 10X Genomics Inc.
o Exhibit 115: 10X Genomics Inc. – Overview
o Exhibit 116: 10X Genomics Inc. – Product / Service
o Exhibit 117: 10X Genomics Inc. – Key offerings
o 12.4 Azenta Inc.
o Exhibit 118: Azenta Inc. – Overview
o Exhibit 119: Azenta Inc. – Business segments
o Exhibit 120: Azenta Inc. – Key offerings
o Exhibit 121: Azenta Inc. – Segment focus
o 12.5 BGI Genomics Co. Ltd.
o Exhibit 122: BGI Genomics Co. Ltd. – Overview
o Exhibit 123: BGI Genomics Co. Ltd. – Product / Service
o Exhibit 124: BGI Genomics Co. Ltd. – Key offerings
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 125: Bio Rad Laboratories Inc. – Overview
o Exhibit 126: Bio Rad Laboratories Inc. – Business segments
o Exhibit 127: Bio Rad Laboratories Inc. – Key news
o Exhibit 128: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 129: Bio Rad Laboratories Inc. – Segment focus
o 12.7 Eurofins Scientific SE
o Exhibit 130: Eurofins Scientific SE – Overview
o Exhibit 131: Eurofins Scientific SE – Business segments
o Exhibit 132: Eurofins Scientific SE – Key news
o Exhibit 133: Eurofins Scientific SE – Key offerings
o Exhibit 134: Eurofins Scientific SE – Segment focus
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 135: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 136: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 137: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 138: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 139: F. Hoffmann La Roche Ltd. – Segment focus
o 12.9 Illumina Inc.
o Exhibit 140: Illumina Inc. – Overview
o Exhibit 141: Illumina Inc. – Business segments
o Exhibit 142: Illumina Inc. – Key news
o Exhibit 143: Illumina Inc. – Key offerings
o Exhibit 144: Illumina Inc. – Segment focus
o 12.10 Konica Minolta Inc.
o Exhibit 145: Konica Minolta Inc. – Overview
o Exhibit 146: Konica Minolta Inc. – Business segments
o Exhibit 147: Konica Minolta Inc. – Key news
o Exhibit 148: Konica Minolta Inc. – Key offerings
o Exhibit 149: Konica Minolta Inc. – Segment focus
o 12.11 Laboratory Corp. of America Holdings
o Exhibit 150: Laboratory Corp. of America Holdings – Overview
o Exhibit 151: Laboratory Corp. of America Holdings – Business segments
o Exhibit 152: Laboratory Corp. of America Holdings – Key news
o Exhibit 153: Laboratory Corp. of America Holdings – Key offerings
o Exhibit 154: Laboratory Corp. of America Holdings – Segment focus
o 12.12 Merck KGaA
o Exhibit 155: Merck KGaA – Overview
o Exhibit 156: Merck KGaA – Business segments
o Exhibit 157: Merck KGaA – Key news
o Exhibit 158: Merck KGaA – Key offerings
o Exhibit 159: Merck KGaA – Segment focus
o 12.13 Perkin Elmer Inc.
o Exhibit 160: Perkin Elmer Inc. – Overview
o Exhibit 161: Perkin Elmer Inc. – Business segments
o Exhibit 162: Perkin Elmer Inc. – Key news
o Exhibit 163: Perkin Elmer Inc. – Key offerings
o Exhibit 164: Perkin Elmer Inc. – Segment focus
o 12.14 QIAGEN NV
o Exhibit 165: QIAGEN NV – Overview
o Exhibit 166: QIAGEN NV – Product / Service
o Exhibit 167: QIAGEN NV – Key news
o Exhibit 168: QIAGEN NV – Key offerings
o 12.15 Standard BioTools Inc.
o Exhibit 169: Standard BioTools Inc. – Overview
o Exhibit 170: Standard BioTools Inc. – Product / Service
o Exhibit 171: Standard BioTools Inc. – Key news
o Exhibit 172: Standard BioTools Inc. – Key offerings
o 12.16 Takara Bio Inc.
o Exhibit 173: Takara Bio Inc. – Overview
o Exhibit 174: Takara Bio Inc. – Business segments
o Exhibit 175: Takara Bio Inc. – Key offerings
o Exhibit 176: Takara Bio Inc. – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 177: Thermo Fisher Scientific Inc. – Overview
o Exhibit 178: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 179: Thermo Fisher Scientific Inc. – Key news
o Exhibit 180: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 181: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global next generation sequencing market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Academic research – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Academic research – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Academic research – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Academic research – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinical research – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinical research – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinical research – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinical research – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by End-user ($ million)
Exhibits51: Data Table on Market opportunity by End-user ($ million)
Exhibits52: Chart on Product – Market share 2022-2027 (%)
Exhibits53: Data Table on Product – Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Equipment – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Equipment – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Equipment – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Equipment – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Product ($ million)
Exhibits65: Data Table on Market opportunity by Product ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: 10X Genomics Inc. – Overview
Exhibits116: 10X Genomics Inc. – Product / Service
Exhibits117: 10X Genomics Inc. – Key offerings
Exhibits118: Azenta Inc. – Overview
Exhibits119: Azenta Inc. – Business segments
Exhibits120: Azenta Inc. – Key offerings
Exhibits121: Azenta Inc. – Segment focus
Exhibits122: BGI Genomics Co. Ltd. – Overview
Exhibits123: BGI Genomics Co. Ltd. – Product / Service
Exhibits124: BGI Genomics Co. Ltd. – Key offerings
Exhibits125: Bio Rad Laboratories Inc. – Overview
Exhibits126: Bio Rad Laboratories Inc. – Business segments
Exhibits127: Bio Rad Laboratories Inc. – Key news
Exhibits128: Bio Rad Laboratories Inc. – Key offerings
Exhibits129: Bio Rad Laboratories Inc. – Segment focus
Exhibits130: Eurofins Scientific SE – Overview
Exhibits131: Eurofins Scientific SE – Business segments
Exhibits132: Eurofins Scientific SE – Key news
Exhibits133: Eurofins Scientific SE – Key offerings
Exhibits134: Eurofins Scientific SE – Segment focus
Exhibits135: F. Hoffmann La Roche Ltd. – Overview
Exhibits136: F. Hoffmann La Roche Ltd. – Business segments
Exhibits137: F. Hoffmann La Roche Ltd. – Key news
Exhibits138: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits140: Illumina Inc. – Overview
Exhibits141: Illumina Inc. – Business segments
Exhibits142: Illumina Inc. – Key news
Exhibits143: Illumina Inc. – Key offerings
Exhibits144: Illumina Inc. – Segment focus
Exhibits145: Konica Minolta Inc. – Overview
Exhibits146: Konica Minolta Inc. – Business segments
Exhibits147: Konica Minolta Inc. – Key news
Exhibits148: Konica Minolta Inc. – Key offerings
Exhibits149: Konica Minolta Inc. – Segment focus
Exhibits150: Laboratory Corp. of America Holdings – Overview
Exhibits151: Laboratory Corp. of America Holdings – Business segments
Exhibits152: Laboratory Corp. of America Holdings – Key news
Exhibits153: Laboratory Corp. of America Holdings – Key offerings
Exhibits154: Laboratory Corp. of America Holdings – Segment focus
Exhibits155: Merck KGaA – Overview
Exhibits156: Merck KGaA – Business segments
Exhibits157: Merck KGaA – Key news
Exhibits158: Merck KGaA – Key offerings
Exhibits159: Merck KGaA – Segment focus
Exhibits160: Perkin Elmer Inc. – Overview
Exhibits161: Perkin Elmer Inc. – Business segments
Exhibits162: Perkin Elmer Inc. – Key news
Exhibits163: Perkin Elmer Inc. – Key offerings
Exhibits164: Perkin Elmer Inc. – Segment focus
Exhibits165: QIAGEN NV – Overview
Exhibits166: QIAGEN NV – Product / Service
Exhibits167: QIAGEN NV – Key news
Exhibits168: QIAGEN NV – Key offerings
Exhibits169: Standard BioTools Inc. – Overview
Exhibits170: Standard BioTools Inc. – Product / Service
Exhibits171: Standard BioTools Inc. – Key news
Exhibits172: Standard BioTools Inc. – Key offerings
Exhibits173: Takara Bio Inc. – Overview
Exhibits174: Takara Bio Inc. – Business segments
Exhibits175: Takara Bio Inc. – Key offerings
Exhibits176: Takara Bio Inc. – Segment focus
Exhibits177: Thermo Fisher Scientific Inc. – Overview
Exhibits178: Thermo Fisher Scientific Inc. – Business segments
Exhibits179: Thermo Fisher Scientific Inc. – Key news
Exhibits180: Thermo Fisher Scientific Inc. – Key offerings
Exhibits181: Thermo Fisher Scientific Inc. – Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations



★調査レポート[次世代シーケンスのグローバル市場2023~2027:学術研究、臨床研究、製薬・バイオテクノロジー企業、その他] (コード:IRTNTR71618-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[次世代シーケンスのグローバル市場2023~2027:学術研究、臨床研究、製薬・バイオテクノロジー企業、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆